Generics - Production, Biotechnology

Filter

Current filters:

ProductionBiotechnology

Popular Filters

US firms establish strategic partnership around biosimilars

06-08-2013

Privately-held Oncobiologics has formed a broad strategic partnership with fellow USA-based inVentiv…

AvastinBiotechnologyErbituxGenericsHerceptinHumiraImmunologicalsinVentive HealthOncobiologicsOncologyProductionResearchRituxan

US payers have more faith in biosimilars from multinationals

22-07-2013

US payer's trust in specific biosimilar manufacturers could dictate which companies will be most successful…

BiotechnologyEuropeGenericsNorth AmericaProductionRegulation

Pfenex and Agila Biotech set up JV to develop biosimilars

16-04-2013

US biotech firm Pfenex Inc. and Agila Biotech, a subsidiary of Indian drugmaker Strides Arcolab (BO:…

Agila BiotechBayerBetaferonBetaseronBiotechnologyGenericsGlobalNeurologicalPfenexProductionResearchStrides Arcolab

Both biosimilar and reference biologics companies must consider product-specific and regional strategies

09-04-2013

With sales forecasted to exceed $16.8 billion by 2021, manufacturers competing in the biosimilars market…

BiotechnologyGenericsMarkets & MarketingPatentsProductionResearch

Russia's Biocad plans to produce high-tech drugs in Brazil

19-03-2013

Biocad, one of Russia's leading biotechnology companies, plans to launch production of several of its…

AvastinBiocadBiotechnologyGenericsHerceptinMabTheraOncologyProductionRocheSouth America

Indian Pharma growth outpaces rivals, but must embrace innovation

12-03-2013

Ranking among the top five globally by production volume, the Indian pharmaceutical market at present…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProductionResearch

Australia's pharma sector a net importer but also one of its largest high-tech exporters

13-01-2013

The pharmaceutical product manufacturing industry in Australia is dominated by major global pharmaceutical…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProduction

Questcor Pharmaceuticals to acquire BioVectra for around $50 million

04-01-2013

California, USA-based Questcor Pharmaceuticals (Nasdaq: QCOR) has signed a definitive agreement to acquire…

BiotechnologyBioVectraGenericsMergers & AcquisitionsPharmaceuticalProductionQuestor Pharmaceuticals

Catalent and UMN Pharma collaborate for biosimilars development and production in Japan

16-12-2012

Privately-held USA-based Catalent Pharma Solutions and Japanese drugmaker UMN Pharma (TYO Mothers: 4585)…

Asia-PacificBiotechnologyCatalent Pharma SolutionsGenericsProductionResearchUMN PharmaVaccines

Biopharmaceuticals promise to boost downstream processing in Asia

04-11-2012

Global contract manufacturing organizations (CMOs) are set to steadily become more and more popular,…

Asia-PacificBiotechnologyGenericsPharmaceuticalProduction

AET BioTech and BioXpress to co-develop biosimilar Humira

02-11-2012

Plans to develop another biosimilar version of Abbott Laboratories blockbuster rheumatoid arthritis drug…

Abbott LaboratoriesadalimumabAET BioTechAnti-Arthritics/RheumaticsBiotechnologyBioXpress TherapeuticsGenericsHumiraProductionResearch

Company Spotlight

ImmunoGen

ImmunoGen

Back to top